AXSOME THERAPEUTICS, INC. Earnings Per Share (Basic)
AXSOME THERAPEUTICS, INC. (AXSM) reported Earnings Per Share (Basic) of -$0.99 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.99.
- AXSOME THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$1.26.
- AXSOME THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.56.
- AXSOME THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.94.
- AXSOME THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$3.68.
- AXSOME THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$5.99.
- AXSOME THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$5.27.
- AXSOME THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$4.60.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.99 10-Q · filed 2026-08-10 | -$2.25 10-Q · filed 2026-08-10 | -$2.82 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$3.76 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2026-03-31 | -$1.26 10-Q · filed 2026-05-04 | -$1.83 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$2.77 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$3.74 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2025-12-31 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$2.47 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$3.68 10-K · filed 2026-02-23 | |
| 2025-09-30 | -$0.94 10-Q · filed 2025-11-03 | -$1.91 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$3.13 10-Q · filed 2025-11-03 | -$4.66 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2025-06-30 | -$0.97 10-Q · filed 2026-08-10 | -$2.18 10-Q · filed 2026-08-10 | -$3.72 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$5.06 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2025-03-31 | -$1.22 10-Q · filed 2026-05-04 | -$2.76 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$4.10 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$5.76 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2024-12-31 | -$1.54 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$2.89 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$4.55 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$5.99 10-K · filed 2026-02-23 | |
| 2024-09-30 | -$1.34 10-Q · filed 2025-11-03 | -$3.01 derived: net income ÷ weighted average shares · filed 2025-11-03 | -$4.45 10-Q · filed 2025-11-03 | -$6.53 derived: net income ÷ weighted average shares · filed 2026-04-24 | |
| 2024-06-30 | -$1.67 10-Q · filed 2025-08-04 | -$3.11 10-Q · filed 2025-08-04 | -$5.19 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$6.52 derived: net income ÷ weighted average shares · filed 2026-04-24 | |
| 2024-03-31 | -$1.44 10-Q · filed 2025-05-05 | -$3.53 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$4.85 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$6.39 derived: net income ÷ weighted average shares · filed 2026-04-24 | |
| 2023-12-31 | -$2.08 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$3.41 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$4.95 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$5.27 10-K · filed 2026-02-23 | |
| 2023-09-30 | -$1.32 10-Q · filed 2024-11-12 | -$2.85 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$3.14 10-Q · filed 2024-11-12 | -$4.54 derived: net income ÷ weighted average shares · filed 2026-04-24 | |
| 2023-06-30 | -$1.54 10-Q · filed 2024-08-05 | -$1.80 10-Q · filed 2024-08-05 | -$3.21 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$4.28 derived: net income ÷ weighted average shares · filed 2026-04-24 | |
| 2023-03-31 | -$0.26 10-Q · filed 2024-05-06 | -$1.67 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$2.73 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$3.78 derived: net income ÷ weighted average shares · filed 2026-04-24 | |
| 2022-12-31 | -$1.41 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$2.49 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$3.56 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$4.60 10-K · filed 2025-02-18 | |
| 2022-09-30 | -$1.07 10-Q · filed 2023-11-06 | -$2.14 derived: net income ÷ weighted average shares · filed 2023-11-06 | -$3.17 10-Q · filed 2023-11-06 | -$4.08 derived: net income ÷ weighted average shares · filed 2026-04-24 | |
| 2022-06-30 | -$1.06 10-Q · filed 2023-08-07 | -$2.09 10-Q · filed 2023-08-07 | -$3.00 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$3.92 derived: net income ÷ weighted average shares · filed 2026-04-24 | |
| 2022-03-31 | -$1.06 10-Q · filed 2023-08-07 | -$1.03 10-Q · filed 2023-05-09 | -$1.93 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$2.86 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$3.72 derived: net income ÷ weighted average shares · filed 2026-04-24 |
| 2021-12-31 | -$0.90 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$1.83 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$2.68 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$3.47 10-K · filed 2024-02-23 | |
| 2021-09-30 | -$0.93 10-Q · filed 2022-11-07 | -$1.78 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$2.57 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | -$0.86 10-Q · filed 2022-08-09 | -$1.64 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | -$2.77 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |